Scoring systems for predicting mortality for severe patients with COVID-19

Background: Coronavirus disease 2019 (COVID-19) has been widely spread and caused tens of thousands of deaths, especially in patients with severe COVID-19. This analysis aimed to explore risk factors for mortality of severe COVID-19, and establish a scoring system to predict in-hospital deaths. Meth...

Full description

Bibliographic Details
Main Authors: Yufeng Shang, Tao Liu, Yongchang Wei, Jingfeng Li, Liang Shao, Minghui Liu, Yongxi Zhang, Zhigang Zhao, Haibo Xu, Zhiyong Peng, Fuling Zhou, Xinghuan Wang
Format: Article
Language:English
Published: Elsevier 2020-07-01
Series:EClinicalMedicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S258953702030170X
id doaj-f96fd86b40204bf18cd0545bff92cc17
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Yufeng Shang
Tao Liu
Yongchang Wei
Jingfeng Li
Liang Shao
Minghui Liu
Yongxi Zhang
Zhigang Zhao
Haibo Xu
Zhiyong Peng
Fuling Zhou
Xinghuan Wang
spellingShingle Yufeng Shang
Tao Liu
Yongchang Wei
Jingfeng Li
Liang Shao
Minghui Liu
Yongxi Zhang
Zhigang Zhao
Haibo Xu
Zhiyong Peng
Fuling Zhou
Xinghuan Wang
Scoring systems for predicting mortality for severe patients with COVID-19
EClinicalMedicine
COVID-19
Critical ill
Scoring system
Antibody
Mortality
author_facet Yufeng Shang
Tao Liu
Yongchang Wei
Jingfeng Li
Liang Shao
Minghui Liu
Yongxi Zhang
Zhigang Zhao
Haibo Xu
Zhiyong Peng
Fuling Zhou
Xinghuan Wang
author_sort Yufeng Shang
title Scoring systems for predicting mortality for severe patients with COVID-19
title_short Scoring systems for predicting mortality for severe patients with COVID-19
title_full Scoring systems for predicting mortality for severe patients with COVID-19
title_fullStr Scoring systems for predicting mortality for severe patients with COVID-19
title_full_unstemmed Scoring systems for predicting mortality for severe patients with COVID-19
title_sort scoring systems for predicting mortality for severe patients with covid-19
publisher Elsevier
series EClinicalMedicine
issn 2589-5370
publishDate 2020-07-01
description Background: Coronavirus disease 2019 (COVID-19) has been widely spread and caused tens of thousands of deaths, especially in patients with severe COVID-19. This analysis aimed to explore risk factors for mortality of severe COVID-19, and establish a scoring system to predict in-hospital deaths. Methods: Patients with COVID-19 were retrospectively analyzed and clinical characteristics were compared. LASSO regression as well as multivariable analysis were used to screen variables and establish prediction model. Findings: A total of 2529 patients with COVID-19 was retrospectively analyzed, and 452 eligible severe COVID-19 were used for finally analysis. In training cohort, the median age was 66•0 years while it was 73•0 years in non-survivors. Patients aged 60–75 years accounted for the largest proportion of infected populations and mortality toll. Anti-SARS-CoV-2 antibodies were monitored up to 54 days, and IgG levels reached the highest during 20–30 days. No differences were observed of antibody levels between severe and non-severe patients. About 60.2% of severe patients had complications. Among acute myocardial injury (AMI), acute kidney injury (AKI) and acute liver injury (ALI), the heart was the earliest injured organ, whereas the time from AKI to death was the shortest. Age, diabetes, coronary heart disease (CHD), percentage of lymphocytes (LYM%), procalcitonin (PCT), serum urea, C reactive protein and D-dimer (DD), were identified associated with mortality by LASSO binary logistic regression. Then multivariable analysis was performed to conclude that old age, CHD, LYM%, PCT and DD remained independent risk factors for mortality. Based on the above variables, a scoring system of COVID-19 (CSS) was established to divide patients into low-risk and high-risk groups. This model displayed good discrimination (AUC=0·919) and calibration (P=0·264). Complications in low-risk and high-risk groups were significantly different (P<0·05). Use of corticosteroids in low-risk groups increased hospital stays by 4·5 days (P=0·036) and durations of disease by 7·5 days (P=0·012) compared with no corticosteroids. Interpretation: Old age, CHD, LYM%, PCT and DD were independently related to mortality. CSS was useful for predicting in-hospital mortality and complications, and it could help clinicians to identify high-risk patients with poor prognosis. Funding: This work was supported by the Key Project for Anti-2019 novel Coronavirus Pneumonia from the Ministry of Science and Technology, China (grant number 2020YFC0845500).
topic COVID-19
Critical ill
Scoring system
Antibody
Mortality
url http://www.sciencedirect.com/science/article/pii/S258953702030170X
work_keys_str_mv AT yufengshang scoringsystemsforpredictingmortalityforseverepatientswithcovid19
AT taoliu scoringsystemsforpredictingmortalityforseverepatientswithcovid19
AT yongchangwei scoringsystemsforpredictingmortalityforseverepatientswithcovid19
AT jingfengli scoringsystemsforpredictingmortalityforseverepatientswithcovid19
AT liangshao scoringsystemsforpredictingmortalityforseverepatientswithcovid19
AT minghuiliu scoringsystemsforpredictingmortalityforseverepatientswithcovid19
AT yongxizhang scoringsystemsforpredictingmortalityforseverepatientswithcovid19
AT zhigangzhao scoringsystemsforpredictingmortalityforseverepatientswithcovid19
AT haiboxu scoringsystemsforpredictingmortalityforseverepatientswithcovid19
AT zhiyongpeng scoringsystemsforpredictingmortalityforseverepatientswithcovid19
AT fulingzhou scoringsystemsforpredictingmortalityforseverepatientswithcovid19
AT xinghuanwang scoringsystemsforpredictingmortalityforseverepatientswithcovid19
_version_ 1724639337194192896
spelling doaj-f96fd86b40204bf18cd0545bff92cc172020-11-25T03:15:27ZengElsevierEClinicalMedicine2589-53702020-07-0124100426Scoring systems for predicting mortality for severe patients with COVID-19Yufeng Shang0Tao Liu1Yongchang Wei2Jingfeng Li3Liang Shao4Minghui Liu5Yongxi Zhang6Zhigang Zhao7Haibo Xu8Zhiyong Peng9Fuling Zhou10Xinghuan Wang11Department of Hematology, Zhongnan Hospital of Wuhan University, 169 Donghu Road, Wuhan 430071, PR ChinaDepartment of Urology, Zhongnan Hospital of Wuhan University, 169 Donghu Road, Wuhan 430071, PR ChinaDepartment of Radiology, Zhongnan Hospital of Wuhan University, Wuhan 430071, PR ChinaDepartment of Orthopedics, Zhongnan Hospital of Wuhan University, Wuhan 430071, PR ChinaDepartment of Hematology, Zhongnan Hospital of Wuhan University, 169 Donghu Road, Wuhan 430071, PR ChinaDepartment of Hematology, Zhongnan Hospital of Wuhan University, 169 Donghu Road, Wuhan 430071, PR ChinaDepartment of Infectious Disease, Zhongnan Hospital of Wuhan University, Wuhan 430071, PR ChinaEmergency Center, Zhongnan Hospital of Wuhan University, Wuhan 430071, PR ChinaDepartment of Radiology, Zhongnan Hospital of Wuhan University, Wuhan 430071, PR ChinaDepartment of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, PR ChinaDepartment of Hematology, Zhongnan Hospital of Wuhan University, 169 Donghu Road, Wuhan 430071, PR China; Corresponding author at: Department of Hematology, Zhongnan Hospital of Wuhan University, 169 Donghu Road, Wuhan 430071, PR China.Department of Urology, Zhongnan Hospital of Wuhan University, 169 Donghu Road, Wuhan 430071, PR China; Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, PR China; Corresponding author.Background: Coronavirus disease 2019 (COVID-19) has been widely spread and caused tens of thousands of deaths, especially in patients with severe COVID-19. This analysis aimed to explore risk factors for mortality of severe COVID-19, and establish a scoring system to predict in-hospital deaths. Methods: Patients with COVID-19 were retrospectively analyzed and clinical characteristics were compared. LASSO regression as well as multivariable analysis were used to screen variables and establish prediction model. Findings: A total of 2529 patients with COVID-19 was retrospectively analyzed, and 452 eligible severe COVID-19 were used for finally analysis. In training cohort, the median age was 66•0 years while it was 73•0 years in non-survivors. Patients aged 60–75 years accounted for the largest proportion of infected populations and mortality toll. Anti-SARS-CoV-2 antibodies were monitored up to 54 days, and IgG levels reached the highest during 20–30 days. No differences were observed of antibody levels between severe and non-severe patients. About 60.2% of severe patients had complications. Among acute myocardial injury (AMI), acute kidney injury (AKI) and acute liver injury (ALI), the heart was the earliest injured organ, whereas the time from AKI to death was the shortest. Age, diabetes, coronary heart disease (CHD), percentage of lymphocytes (LYM%), procalcitonin (PCT), serum urea, C reactive protein and D-dimer (DD), were identified associated with mortality by LASSO binary logistic regression. Then multivariable analysis was performed to conclude that old age, CHD, LYM%, PCT and DD remained independent risk factors for mortality. Based on the above variables, a scoring system of COVID-19 (CSS) was established to divide patients into low-risk and high-risk groups. This model displayed good discrimination (AUC=0·919) and calibration (P=0·264). Complications in low-risk and high-risk groups were significantly different (P<0·05). Use of corticosteroids in low-risk groups increased hospital stays by 4·5 days (P=0·036) and durations of disease by 7·5 days (P=0·012) compared with no corticosteroids. Interpretation: Old age, CHD, LYM%, PCT and DD were independently related to mortality. CSS was useful for predicting in-hospital mortality and complications, and it could help clinicians to identify high-risk patients with poor prognosis. Funding: This work was supported by the Key Project for Anti-2019 novel Coronavirus Pneumonia from the Ministry of Science and Technology, China (grant number 2020YFC0845500).http://www.sciencedirect.com/science/article/pii/S258953702030170XCOVID-19Critical illScoring systemAntibodyMortality